Progyny reports second-quarter non-GAAP EPS of $0.55 and revenue growth of 5.3% year-over-year.
Progyny posted second-quarter non-GAAP earnings per share of $0.55, exceeding estimates by $0.03. Revenue reached $350.5 million, up 5.3% from the same period last year and $1.85 million above expectations.
The company’s revenue growth reflects a year-over-year increase from $332.9 million in Q2 2025. The results highlight continued expansion in its core business segments.
Shares showed limited immediate reaction in after-hours trading following the release.